XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Parent
Cumulative Effect of Adoption
Parent
As Adjusted Balance
Parent
Common Stock
As Adjusted Balance
Common Stock
Capital in Excess of Par Value
As Adjusted Balance
Capital in Excess of Par Value
Cumulative Net Income
Cumulative Effect of Adoption
Cumulative Net Income
As Adjusted Balance
Cumulative Net Income
Cumulative Distributions
As Adjusted Balance
Cumulative Distributions
Non-controlling Interests
As Adjusted Balance
Non-controlling Interests
Cumulative Effect of Adoption
As Adjusted Balance
Total
Balance at beginning of period at Dec. 31, 2018 $ (42,808) $ 782,682 $ 825,490 $ 397 $ 397 $ 862,712 $ 862,712 $ (42,808) $ 1,212,956 $ 1,255,764 $ (1,293,383) $ (1,293,383) $ 7,481 $ 7,481 $ (42,808) $ 790,163 $ 832,971
Balance (in shares) at Dec. 31, 2018       39,657 39,657                        
Equity activity                                  
Common stock cash distributions     (22,631)                 (22,631)         (22,631)
Vesting of performance-based stock units     (300)                 (300)         (300)
Vesting of performance-based stock units (in shares)         48                        
Issuance of restricted stock     (1)       (1)                   (1)
Issuance of restricted stock (in shares)         78                        
Stock-based compensation expense     1,689       1,689                   1,689
Net income     20,346             20,346       81     20,427
Non-controlling interests contributions                           919     919
Non-controlling interest distributions                           (89)     (89)
Other     (2,024)       (2,024)                   (2,024)
Other (in shares)         (44)                        
Balance at end of period at Mar. 31, 2019     779,761   $ 397   862,376     1,233,302   (1,316,314)   8,392     788,153
Balance (in shares) at Mar. 31, 2019         39,739                        
Balance at beginning of period at Dec. 31, 2018 $ (42,808) $ 782,682 825,490 $ 397 $ 397 $ 862,712 862,712 $ (42,808) $ 1,212,956 1,255,764 $ (1,293,383) (1,293,383) $ 7,481 7,481 $ (42,808) $ 790,163 832,971
Balance (in shares) at Dec. 31, 2018       39,657 39,657                        
Equity activity                                  
Net income                                 68,241
Balance at end of period at Sep. 30, 2019     785,434   $ 398   865,721     1,280,940   (1,361,625)   8,460     793,894
Balance (in shares) at Sep. 30, 2019         39,752                        
Balance at beginning of period at Mar. 31, 2019     779,761   $ 397   862,376     1,233,302   (1,316,314)   8,392     788,153
Balance (in shares) at Mar. 31, 2019         39,739                        
Equity activity                                  
Common stock cash distributions     (22,653)                 (22,653)         (22,653)
Issuance of restricted stock     (6)       (6)                   (6)
Issuance of restricted stock (in shares)         8                        
Stock-based compensation expense     1,623       1,623                   1,623
Net income     20,446             20,446       88     20,534
Non-controlling interests contributions                           46     46
Non-controlling interest distributions                           (87)     (87)
Balance at end of period at Jun. 30, 2019     779,171   $ 397   863,993     1,253,748   (1,338,967)   8,439     787,610
Balance (in shares) at Jun. 30, 2019         39,747                        
Equity activity                                  
Common stock cash distributions     (22,658)                 (22,658)         (22,658)
Stock option exercises     123   $ 1   122                   123
Stock option exercises (in shares)         5                        
Stock-based compensation expense     1,626       1,626                   1,626
Net income     27,192             27,192       88     27,280
Non-controlling interest distributions                           (67)     (67)
Other     (20)       (20)                   (20)
Balance at end of period at Sep. 30, 2019     785,434   $ 398   865,721     1,280,940   (1,361,625)   8,460     793,894
Balance (in shares) at Sep. 30, 2019         39,752                        
Equity activity                                  
Common stock cash distributions     (22,658)                 (22,658)         (22,658)
Stock-based compensation expense     1,625       1,625                   1,625
Net income     12,542             12,542       89     12,631
Non-controlling interest distributions                           (66)     (66)
Balance at end of period at Dec. 31, 2019     776,943   $ 398   867,346     1,293,482   (1,384,283)   8,483     785,426
Balance (in shares) at Dec. 31, 2019         39,752                        
Equity activity                                  
Common stock cash distributions     (22,581)                 (22,581)         (22,581)
Vesting of performance-based stock units     (586)                 (586)         (586)
Vesting of performance-based stock units (in shares)         82                        
Issuance of restricted stock         $ 1   (1)                    
Issuance of restricted stock (in shares)         76                        
Repurchase of common stock     (18,012)   $ (6)   (18,006)                   (18,012)
Repurchase of common stock (in shares)         (616)                        
Stock-based compensation expense     1,777       1,777                   1,777
Net income     63,633             63,633       89     63,722
Non-controlling interest distributions                           (146)     (146)
Other     (3,545)   $ (1)   (3,544)                   (3,545)
Other (in shares)         (76)                        
Balance at end of period at Mar. 31, 2020     797,629   $ 392   847,572     1,357,115   (1,407,450)   8,426     806,055
Balance (in shares) at Mar. 31, 2020         39,218                        
Balance at beginning of period at Dec. 31, 2019     776,943   $ 398   867,346     1,293,482   (1,384,283)   8,483     785,426
Balance (in shares) at Dec. 31, 2019         39,752                        
Equity activity                                  
Net income                                 78,012
Balance at end of period at Sep. 30, 2020     770,417   $ 392   851,000     1,371,202   (1,452,177)   8,404     778,821
Balance (in shares) at Sep. 30, 2020         39,242                        
Balance at beginning of period at Mar. 31, 2020     797,629   $ 392   847,572     1,357,115   (1,407,450)   8,426     806,055
Balance (in shares) at Mar. 31, 2020         39,218                        
Equity activity                                  
Common stock cash distributions     (22,359)                 (22,359)         (22,359)
Issuance of restricted stock     (7)       (7)                   (7)
Issuance of restricted stock (in shares)         25                        
Stock-based compensation expense     1,761       1,761                   1,761
Net income     1,870             1,870       82     1,952
Non-controlling interest distributions                           (97)     (97)
Balance at end of period at Jun. 30, 2020     778,894   $ 392   849,326     1,358,985   (1,429,809)   8,411     787,305
Balance (in shares) at Jun. 30, 2020         39,243                        
Equity activity                                  
Common stock cash distributions     (22,368)                 (22,368)         (22,368)
Stock-based compensation expense     1,693       1,693                   1,693
Net income     12,217             12,217       121     12,338
Non-controlling interest distributions                           (128)     (128)
Other     (19)       (19)                   (19)
Other (in shares)         (1)                        
Balance at end of period at Sep. 30, 2020     $ 770,417   $ 392   $ 851,000     $ 1,371,202   $ (1,452,177)   $ 8,404     $ 778,821
Balance (in shares) at Sep. 30, 2020         39,242